Stevens Capital Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Stevens Capital Partners's LLY Position: Q3 2026 in Review
Stevens Capital Partners increased its Eli Lilly (LLY) stake by 33% in Q3 2026, buying an estimated $197K and bringing the position to 668 shares worth $773K. The position accounts for 0.13% of the portfolio, ranked #85.
Stevens Capital Partners first reported a position in LLY in Q4 2025 and has held it in 4 quarters since. 2,846 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Stevens Capital Partners held 668 shares of Eli Lilly worth $773K as of Q3 2026.
- Stevens Capital Partners bought 167 Eli Lilly shares in Q3 2026, an estimated $197K.
- Eli Lilly made up 0.13% of Stevens Capital Partners's portfolio in Q3 2026, its #85 holding.
- Stevens Capital Partners first reported a position in Eli Lilly in Q4 2025 and has held it in 4 quarters since.
- 2,846 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Stevens Capital Partners's 13F filing for Q3 2026, filed 29 Oct 2026.